Bispecific Monoclonal Antibody Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
OABI | F | OmniAb, Inc. | -2.16 | |
ZYME | C | Zymeworks Inc. | 0.32 |
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Bispecific Monoclonal Antibody stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IDNA | D | iShares Genomics Immunology and Healthcare ETF | 0.45 | |
IWC | C | iShares Microcap ETF | 0.28 | |
IWN | C | iShares Russell 2000 Value ETF | 0.08 | |
IBBQ | D | Invesco Nasdaq Biotechnology ETF | 0.05 | |
ESML | B | iShares MSCI USA Small-Cap ESG Optimized ETF | 0.05 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Sep 27 | ZYME | Zymeworks Approaching A Moment Of Truth With Zanidatamab |
Related Industries:
Biotechnology
- Bispecific Monoclonal Antibody
A bispecific monoclonal antibody (bsMAb) is a type of antibody that is engineered to bind to two different antigens simultaneously. This type of antibody has the potential to be used in a variety of therapeutic applications, such as cancer immunotherapy, autoimmune diseases, and infectious diseases. BsMAbs can be used to target two different antigens on the same cell, or two different antigens on different cells. This allows for more precise targeting of the desired antigen, and can potentially reduce the side effects associated with traditional monoclonal antibody therapies.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles